Healthcare Regulatory & Qui Tam Defense Insurance in Massachusetts

Massachusetts at a glance

State false claims statute

Massachusetts False Claims Act

Authorizes qui tam relator suits alongside AG civil recovery authority.

Fraud enforcement office

Attorney General's Medicaid Fraud Division

A federally certified Medicaid Fraud Control Unit handling civil and criminal referrals.

Cost-oversight body

Health Policy Commission cost-growth benchmark

A Massachusetts-specific mechanism that can trigger Performance Improvement Plan review, distinct from fraud enforcement.

Insurance regulator

Massachusetts Division of Insurance

Confirm current licensing and filing guidance directly with the division.

The Health Policy Commission's cost-growth benchmark is a Massachusetts-specific layer

Massachusetts uniquely created a Health Policy Commission that sets an annual health care cost-growth benchmark and can require a Performance Improvement Plan from providers or payers whose cost trends exceed it. This is not a fraud-enforcement mechanism by itself, but Commission data-collection authority and market-impact reviews of proposed transactions can surface billing or referral patterns that later inform an AG Medicaid Fraud Division inquiry, so providers should treat Commission filings as potentially relevant to broader regulatory exposure.

Attorney General's Medicaid Fraud Division and its civil investigative demand practice

The Massachusetts AG's Medicaid Fraud Division is a federally certified Medicaid Fraud Control Unit that pursues both civil recoveries under the state False Claims Act and criminal referrals for provider fraud and patient abuse in long-term care settings. A civil investigative demand from this division can proceed while a qui tam relator's sealed complaint is pending review, since Massachusetts law does not require the AG to disclose an active seal proceeding to the target of a related administrative demand.

Boston-Cambridge research density and marketing-arrangement review

The Boston-Cambridge life-sciences and teaching-hospital cluster means clinical-trial payments, device and pharmaceutical marketing relationships, and faculty practice compensation structures draw sustained attention from the Medicaid Fraud Division and from federal enforcers reviewing the same institutions. A documented process for screening exclusions, reviewing referral arrangements, and escalating suspected overpayments internally remains the practical control; restitution, fines, and knowing violations are not insurable outcomes anywhere, Massachusetts included.

Verify current benchmark rules and AG practice before relying on this summary

The Health Policy Commission's benchmark percentage and the Medicaid Fraud Division's civil investigative demand procedures are both subject to periodic revision; confirm the current rules with counsel for any live matter.

Who we write this for in Massachusetts

Healthcare regulatory defense FAQs for Massachusetts